Tag: GTCR
-
Zentiva’s Major Ownership Shift: Impact on Generic Medications in Romania
Zentiva’s Ownership Change: A New Era for Romania’s Generics Zentiva, the largest producer of generic medications in Romania, is set for a significant ownership change as it prepares to be acquired by the American private equity firm GTCR. This transaction, valued at a staggering 4.1 billion euros, marks a pivotal moment in the Romanian pharmaceutical…
-
Zentiva’s Ownership Change: What It Means for Romania’s Pharma Sector
Overview of Zentiva’s Acquisition Zentiva, the largest producer of generic medicines in Romania, is making headlines with its recent acquisition by GTCR, an American private equity firm. This deal, valued at an astounding €4.1 billion, signifies a substantial shift in the pharmaceutical landscape of Romania and highlights the growing interest of foreign investors in the…
-
Zentiva Sold: A New Era for Romania’s Pharma Industry
Zentiva’s Major Transition in Ownership Zentiva, the largest producer of generic medicines in Romania, is undergoing a significant change in ownership. The Czech pharmaceutical group has entered into an agreement with American private equity firm GTCR for a staggering €4.1 billion. This acquisition not only marks a pivotal development for Zentiva but also signals a…